nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—Macular oedema—Niacin—atherosclerosis	0.0966	0.195	CcSEcCtD
Difluprednate—Panophthalmitis—Pravastatin—atherosclerosis	0.0952	0.192	CcSEcCtD
Difluprednate—Endophthalmitis—Pravastatin—atherosclerosis	0.0488	0.0982	CcSEcCtD
Difluprednate—Pregnancy—Lovastatin—atherosclerosis	0.0484	0.0975	CcSEcCtD
Difluprednate—Pregnancy—Simvastatin—atherosclerosis	0.0453	0.0912	CcSEcCtD
Difluprednate—Betamethasone—PLA2G1B—atherosclerosis	0.0388	0.454	CrCbGaD
Difluprednate—Eye irritation—Lovastatin—atherosclerosis	0.0322	0.0648	CcSEcCtD
Difluprednate—Dexamethasone—PLA2G1B—atherosclerosis	0.0226	0.264	CrCbGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.0178	0.0427	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.0144	0.0345	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.0136	0.0327	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.0134	0.0321	CbGpPWpGaD
Difluprednate—Weight increased—Pravastatin—atherosclerosis	0.0133	0.0267	CcSEcCtD
Difluprednate—Vision blurred—Lovastatin—atherosclerosis	0.0113	0.0228	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.0113	0.027	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.0111	0.0265	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RETN—atherosclerosis	0.011	0.0263	CbGpPWpGaD
Difluprednate—Vision blurred—Simvastatin—atherosclerosis	0.0106	0.0213	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.0105	0.0251	CbGpPWpGaD
Difluprednate—Dexamethasone—NOS2—atherosclerosis	0.0101	0.118	CrCbGaD
Difluprednate—NR3C1—Circadian Clock—F7—atherosclerosis	0.00993	0.0238	CbGpPWpGaD
Difluprednate—Vision blurred—Niacin—atherosclerosis	0.00972	0.0196	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00966	0.0231	CbGpPWpGaD
Difluprednate—Vision blurred—Pravastatin—atherosclerosis	0.00957	0.0193	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.00891	0.0213	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.00849	0.0203	CbGpPWpGaD
Difluprednate—Pruritus—Rosuvastatin—atherosclerosis	0.00818	0.0165	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.00771	0.0185	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.00755	0.0181	CbGpPWpGaD
Difluprednate—Headache—Rosuvastatin—atherosclerosis	0.00725	0.0146	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00696	0.0167	CbGpPWpGaD
Difluprednate—Pruritus—Lovastatin—atherosclerosis	0.00694	0.014	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00684	0.0164	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00684	0.0164	CbGpPWpGaD
Difluprednate—Pruritus—Ezetimibe—atherosclerosis	0.0068	0.0137	CcSEcCtD
Difluprednate—Pruritus—Simvastatin—atherosclerosis	0.00649	0.0131	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00648	0.0155	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.00637	0.0152	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.0063	0.0151	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.00624	0.0149	CbGpPWpGaD
Difluprednate—Headache—Lovastatin—atherosclerosis	0.00614	0.0124	CcSEcCtD
Difluprednate—Triamcinolone—PTGS2—atherosclerosis	0.00608	0.0711	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00602	0.0144	CbGpPWpGaD
Difluprednate—Headache—Ezetimibe—atherosclerosis	0.00602	0.0121	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.00601	0.0144	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00596	0.0143	CbGpPWpGaD
Difluprednate—Pruritus—Niacin—atherosclerosis	0.00596	0.012	CcSEcCtD
Difluprednate—Pruritus—Pravastatin—atherosclerosis	0.00586	0.0118	CcSEcCtD
Difluprednate—Headache—Simvastatin—atherosclerosis	0.00574	0.0116	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.00574	0.0137	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00561	0.0134	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.00544	0.013	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.0054	0.0129	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.0054	0.0129	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00535	0.0128	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.00534	0.0128	CbGpPWpGaD
Difluprednate—Headache—Niacin—atherosclerosis	0.00527	0.0106	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.00527	0.0126	CbGpPWpGaD
Difluprednate—Headache—Pravastatin—atherosclerosis	0.00519	0.0105	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.00513	0.0123	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.00499	0.0119	CbGpPWpGaD
Difluprednate—Betamethasone—PTGS2—atherosclerosis	0.00498	0.0582	CrCbGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00493	0.0118	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00475	0.0114	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.00454	0.0109	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00448	0.0107	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00431	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00419	0.01	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.00418	0.01	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00414	0.00991	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.004	0.00957	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00373	0.00893	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.00369	0.00884	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00364	0.00872	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.00363	0.0087	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00358	0.00858	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00321	0.00768	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LPL—atherosclerosis	0.00319	0.00765	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.00314	0.00752	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00307	0.00734	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.00292	0.00699	CbGpPWpGaD
Difluprednate—Dexamethasone—PTGS2—atherosclerosis	0.0029	0.0339	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.00282	0.00675	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00281	0.00673	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.00277	0.00662	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AGT—atherosclerosis	0.00273	0.00654	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LEP—atherosclerosis	0.00268	0.00641	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.00264	0.00632	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.00257	0.00616	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.00233	0.00558	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.0023	0.00551	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—INS—atherosclerosis	0.00229	0.00547	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.00226	0.00542	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.00223	0.00533	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.00221	0.0053	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.00219	0.00525	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.00218	0.00521	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.0021	0.00503	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.00198	0.00473	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.00164	0.00393	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.00162	0.00389	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.00154	0.00368	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00154	0.00368	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.00147	0.00353	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.00144	0.00346	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.00143	0.00342	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.00138	0.00329	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.00135	0.00322	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.00133	0.00319	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.00133	0.00317	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.00125	0.00299	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—atherosclerosis	0.00124	0.00296	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.00107	0.00256	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.00103	0.00247	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000999	0.00239	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000933	0.00223	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.000878	0.0021	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000864	0.00207	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000851	0.00204	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000782	0.00187	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000767	0.00184	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000741	0.00177	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.000597	0.00143	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARA—atherosclerosis	0.000496	0.00119	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR1—atherosclerosis	0.000449	0.00108	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—atherosclerosis	0.00041	0.000981	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—atherosclerosis	0.000369	0.000884	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MAPK3—atherosclerosis	0.00024	0.000575	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—atherosclerosis	0.000162	0.000388	CbGpPWpGaD
